Do We Get Samples of the Report?

Yes, you will receive a sample copy of the market research report from the sales team when you put a query to us. The sample report is free and offers a brief view of the report and information on data available before you purchase the full-fledged report. Also, we will provide a demo sample for any oncoming study.

How to Buy a Market Report?

Select the report you wish to purchase and proceed to buy it by making an online payment. We use a secured gateway for payment transfers and do not share your financial information with any unconcerned third party.

In Which Format Will I Get the Report?

The report will be delivered in spreadsheet and PDF format. In some cases, PPT formats could be available as well.

In How Much Time I will Get the Report After Purchase?

After confirmation of the payment, you will receive the electronic format of the report at your registered email address in (mention the timeline for the delivery). If you buy a report over a holiday or weekend, we will process the request the next working day.

How Can I Get the Report Customized?

Market studies and reports already contain important data and are ready for distribution to the purchaser. However, if there is any particular query, addition, or customization you require, then contact us on our email id or phone. We will look to accommodate your request and see what can be done at the earliest. The research team will design the report accordingly and discuss the solutions beforehand with you.

How Much Will It Cost to Get a Report Customized?

The price of the customized report will be conveyed to you by our team after we agree on the deliverable. A delivery timeline will be set so that you get the report within the expected date. Any requests for customizations after selling the report will be handled by a separate department and the prices for the same mentioned upfront.

Can I Buy Only a Particular Segment of the Study?

While usually such a request is not accommodated as any market research report is wholesome and the cost of the report is for overall contents, in special cases, we may be able to sell select segments of the report based on your requirements.

Is There Any Available Discount?

Our team will love to support academicians, start-ups, students, and others with consulting and research. Thus, our pricing plan is based on keeping these interests in mind and is already affordable. However, we may have discounts available for particular customer types and reports. So, contact us for more information.

Which Services Are Complimentary Before Purchasing the Report?

We have consumer-centric reports and offer several facilities before selling. You will get a free review and sample report, talk to our customer care team for any additions to be done and meet special requirements, and interact with our analysts for deeper understanding.

Will I Receive a Bill or Invoice for the Report Purchased?

Yes, you will get an invoice for the purchase you made. The invoice will be sent to you electronically on your registered email id.

What If I am Unable to Find the Report in the Catalog?

We have a vast database of market reports and studies and there are a few which may not have been uploaded yet. If you are unable to find the one you want, then get in touch with our sales team by phone or email and we will connect with you for assistance.

How Often Are the Existing Studies Updated?

Not every study is the same. Thus, the update for reports will depend on the ongoing research and changes if any to be incorporated in the document or not.

What If the Report Does Not Contain the Information I Want?

The market research reports are constructed keeping in mind the industry trends, nature of the study, and required inputs. But if you want something more than what is stated in the report, we can help you out with further research if possible. Contact us right away, and we will do the needful to aid you.

Is the Payment Refundable?

Once the payment is done, it is non-refundable because as per the standard policy, the utility of the reports is based on knowledge sharing, and thus, a refund is not possible to make after we have issued you obtain the study. To avoid the hassle, we have a detailed view of the report and its ideas through a sample report.

What If the Payment Fails?

If the payment fails then be assured that you shall receive the money back to the source payment mode from the payment gateway. Aarkstore is not responsible for any loss of payment in the process.

Can I Avail the Report of a Particular Country/Region?

Yes, we can provide a report or segment related to a particular region or geography if we have that feature available for the document.

Do You Offer Support After Purchase?

Yes, we are here to solve any queries you may have for the report from our analyst till a given timeframe. To understand more about this, get in touch with us.

Miracor Medical Systems GmbH - Product Pipeline Analysis, 2017 Update

DESCRIPTION

TABLE OF CONTENTS

RELATED REPORTS

SAMPLE REQUEST

REVIEWS

DESCRIPTION

Summary

Miracor Medical Systems GmbH (Miracor Medical) is a medical device company that develops and commercializes pressure-controlled intermittent coronary sinus occlusions. The company offers products for continuous monitoring of coronary sinus pressure dynamics. It offers impulse console and impulse catheter, which are based on proprietary platform PICSO technology. Miracor Medicals technology is used for treatment of acute ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction. The company also conducts post market clinical trials on PICSO impulse system in heart attack patients undergoing coronary revascularization with percutaneous coronary intervention. Miracor Medical is headquartered in Vienna, Austria.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Miracor Medical Systems GmbH
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

TABLE OF CONTENTS

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Miracor Medical Systems GmbH Company Overview 4
Miracor Medical Systems GmbH Company Snapshot 4
Miracor Medical Systems GmbH Pipeline Products and Ongoing Clinical Trials Overview 4
Miracor Medical Systems GmbH Pipeline Analysis Overview 7
Miracor Medical Systems GmbH - Key Facts 7
Miracor Medical Systems GmbH - Major Products and Services 8
Miracor Medical Systems GmbH Pipeline Products by Development Stage 9
Miracor Medical Systems GmbH Ongoing Clinical Trials by Trial Status 11
Miracor Medical Systems GmbH Pipeline Products Overview 13
PICSO HF 13
PICSO HF Product Overview 13
PICSO Impulse System 14
PICSO Impulse System Product Overview 14
PICSO Impulse System Clinical Trial 15
PiCSOAMI Impulse Console CABG 16
PiCSOAMI Impulse Console CABG Product Overview 16
PiCSOAMI Impulse Console CABG Clinical Trial 17
Miracor Medical Systems GmbH - Key Competitors 18
Miracor Medical Systems GmbH - Key Employees 19
Miracor Medical Systems GmbH - Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Miracor Medical Systems GmbH, Recent Developments 21
Jun 06, 2017: Miracor Announces Positive Interim Clinical Data with Novel PiCSO Impulse System for AMI Patients 21
Dec 10, 2015: Antonio Colombo, MD appointed Member of the Scientific Advisory Council of Miracor Medical Systems 21
Oct 29, 2015: Miracors PiCSO Impulse System Highlighted as Novel Therapy for Cardioprotected PCI at TCT 2015 in San Francisco 22
Sep 21, 2015: Miracor Medical Systems Launches PiCSO Impulse System In Asia 22
Jun 30, 2015: Miracor Medical Systems appoints international Scientific Advisory Council 23
Mar 31, 2015: Miracor Medical Systems Increases Clinical and Commercial Activities in the UK 24
Jan 08, 2015: Miracor Medical Systems receives additional funding to accelerate clinical validation and commercialization of its PICSO Impulse System 24
Sep 25, 2014: Clinical trial results presented at TCT 2014 show enhanced myocardial recovery in Acute Myocardial Infarction patients treated with the Miracor PICSO Impulse System 25
Sep 09, 2014: New clinical trial results for Miracors PICSO Impulse System in Acute Myocardial Infarction will be reported at TCT 2014 26
Jul 22, 2014: Miracor Medical Systems begins European launch of its next-generation PICSO Impulse System, designed to reduce severe heart attack impairment when used as an adjunct therapy with angioplasty in acute STEMI and NSTEMI patients 27
Appendix 28
Methodology 28
About GlobalData 30
Contact Us 30
Disclaimer 31

List Of Tables

Miracor Medical Systems GmbH Pipeline Products and Ongoing Clinical Trials Overview 4
Miracor Medical Systems GmbH Pipeline Products by Equipment Type 5
Miracor Medical Systems GmbH Pipeline Products by Indication 6
Miracor Medical Systems GmbH Ongoing Clinical Trials by Trial Status 6
Miracor Medical Systems GmbH, Key Facts 7
Miracor Medical Systems GmbH, Major Products and Services 8
Miracor Medical Systems GmbH Number of Pipeline Products by Development Stage 9
Miracor Medical Systems GmbH Pipeline Products Summary by Development Stage 10
Miracor Medical Systems GmbH Ongoing Clinical Trials by Trial Status 11
Miracor Medical Systems GmbH Ongoing Clinical Trials Summary 12
PICSO HF - Product Status 13
PICSO HF - Product Description 13
PICSO Impulse System - Product Status 14
PICSO Impulse System - Product Description 14
PICSO Impulse System - Oxford Acute Myocardial Infarction-pressure-controlled Intermittent Coronary Sinus Occlusion in STEMI: OxAMI-PICSO study 15
PICSO Impulse System - Pressure Controlled Intermittent Coronary Sinus Occlusion as an Adjunct to PCI in Acute Coronary Syndrome. (An Observational Study Evaluating the Effect of PICSO Treatment Concomitant to pPCI in Patients with Anterior NSTEMI or Following pPCI in STEMI) (An Observational Study Evaluating the Effect of PICSO Treatment Concomitant to PPCI in Patients with Anterior NSTEMI or Following pPCI in STEMI) 15
PiCSOAMI Impulse Console CABG - Product Status 16
PiCSOAMI Impulse Console CABG - Product Description 16
PiCSOAMI Impulse Console CABG - Pressure Controlled Intermittent Coronary Sinus Occlusion as an Adjunct to PCI in Acute Coronary Syndrome. (An Observational Study Evaluating the Effect of PICSO Treatment Concomitant to pPCI in Patients with Anterior NSTEMI or Following pPCI in STEMI) (An Observational Study Evaluating the Effect of PICSO Treatment Concomitant to PPCI in Patients with Anterior NSTEMI or Following pPCI in STEMI) 17
Miracor Medical Systems GmbH, Key Employees 19
Miracor Medical Systems GmbH, Subsidiaries 20
Glossary 29

List Of Figures

Miracor Medical Systems GmbH Pipeline Products by Equipment Type 5
Miracor Medical Systems GmbH Pipeline Products by Development Stage 9
Miracor Medical Systems GmbH Ongoing Clinical Trials by Trial Status 11

RELATED REPORTS

Canon Medical Systems Full Year Operating

Canon Medical Systems 2023 Full Year Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Diagnostic Imaging Industry This report is part of

USD 750 View Report

Canon Medical Systems 2023 Third Quarter Operating and Financial Review

Canon Medical Systems 2023 Third Quarter Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Diagnostic Imaging Industry This report is part of

USD 750 View Report

SAMPLE REQUEST

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

REVIEWS

There is no Reviews available

Search and Get the Latest Market Research Reports

Miracor Medical Systems GmbH - Product Pipeline Analysis, 2017 Update

Canon Medical Systems Full Year Operating

Canon Medical Systems 2023 Third Quarter Operating and Financial Review

FAQs